Concepedia

Publication | Open Access

CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study

DOIFull Paper Access

21

Citations

12

References

2017

Year

Philip J. Mease, Juan José Jaller, Tasanee Kitumnuaypong, Worawit Louthrenoo, H. Mann, Galina Matsievskaia, Enrique R. Soriano, Bin Jia, Caihong Wang, Jing Nie,
The Journal of Rheumatology

Abstract

CNTO6785 was well tolerated, but did not demonstrate clinical efficacy in patients with active RA with inadequate response to MTX.

References

YearCitations

Page 1